LUPIN.NS Cash Flow
Lupin Ltd.
Profit & Loss Balance Sheet Cash Flow
Cash Flow · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 23:36
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Net Cash from Operating Activities | ₹19.34 Bn | ₹34.90 Bn | ₹4.30 Bn | ₹75.46 Bn | CashFlowsFromUsedInOperatingActivities |
| Net Cash from Investing Activities | ₹-13.24 Bn | ₹-15.54 Bn | ₹-16.02 Bn | ₹-40.76 Bn | CashFlowsFromUsedInInvestingActivities |
| Net Cash from Financing Activities | ₹-3.37 Bn | ₹-21.84 Bn | ₹17.32 Bn | ₹-8.46 Bn | CashFlowsFromUsedInFinancingActivities |
| Effect of Exchange Rate Changes | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | EffectOfExchangeRateChangesOnCashAndCashEquivalents |
| Net Increase/(Decrease) in Cash | ₹2.73 Bn | ₹-2.48 Bn | ₹5.60 Bn | ₹26.24 Bn | IncreaseDecreaseInCashAndCashEquivalents |
| Cash and Cash Equivalents (Closing) | ₹9.91 Bn | ₹12.32 Bn | N/A | N/A | CashAndCashEquivalentsCashFlowStatement |
Every figure above is the exact value of the named XBRL element from LUPIN.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).